Skip to main content
Equibles

SAMLYN CAPITAL, LLC

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1421097 New York, NY
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,518,657
+$15,511,077 QoQ
Shares Held
400,075
+0.9% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#44
of 265 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SAMLYN CAPITAL, LLC holds $419,609,524 across 10 Biotechnology names. SYRE ranks #7 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 732,568 $78,106,398
2 AXSM
Axsome Therapeutics, Inc.
 246,015 $60,217,090
3 RCUS
Arcus Biosciences, Inc.
 1,547,182 $47,699,619
4 ELVN
Enliven Therapeutics, Inc.
 912,637 $46,316,326
5 ERAS
Erasca, Inc.
 2,256,986 $41,347,982
6 DYN
Dyne Therapeutics, Inc.
 1,754,708 $38,972,063
7 SYRE
Spyre Therapeutics, Inc.
This page 		400,075 $35,518,657
8 RVMD
Revolution Medicines, Inc.
 151,290 $28,333,589

All Filings in SYRE

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,518,657 400,075
2026-03-31 $20,007,580 396,661